Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-26 @ 2:11 AM
Study NCT ID:
NCT03478605
Status:
UNKNOWN
Last Update Posted:
2018-07-05
First Post:
2018-03-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis
Sponsor:
Blokhin's Russian Cancer Research Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-25
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-14
First Submit QC Date:
None
Study First Post Date:
2018-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-02
Last Update Post Date:
2018-07-05
Last Update Post Date Type:
ACTUAL